Smart Equity Invest

← Results dashboard

Q2 FY27 · NSE: JGCHEM

J.G.Chemicals

Results filed 3 November 2026 · Market cap ₹2,302 crore · PE 26.3

GrowthGuidance maintainedTranscript read

Revenue
+63.9%
on a year ago
EBITDA
+111.9%
on a year ago
Profit to shareholders
+85.5%
on a year ago
EBITDA margin
10.5%
−0.1 pts on last quarter

JG Chemicals reported Q2 FY27 consolidated revenue of ₹361.01 crore, up 63.9% YoY, driven by mid-teens volume growth and higher LME-linked selling prices. EBITDA rose 76.8% YoY to ₹38.65 crore with an EBITDA margin of 10.71%, although margins declined slightly sequentially due to raw material timing lags. Commissioning of the 15,000 MTPA Dahej Phase 1 facility is scheduled for trial runs in December 2026, alongside the 5,000 MTPA Naidupeta expansion slated for January 2027.

J.G.Chemicals Limited, Q2 FY27₹ crore, consolidated
Q2 FY27Q1 FY27vs previous quarterQ2 FY26vs a year ago
Revenue361316+14.4%220+63.9%
Operating profit (EBIT)36.8132.35+13.8%16.66+120.9%
Operating margin10.2%10.2%−5 bps7.6%+263 bps
Other income0.572.73−79.1%3.9−85.4%
Exceptional items00–0–
Profit before exceptional items and tax37.2434.97+6.5%20.35+83.0%
Profit to shareholders26.725.08+6.5%14.39+85.5%
Earnings per share (₹)6.816.40+6.4%3.67+85.6%

Source: J.G.Chemicals Limited’s filing to NSE, 3 November 2026. Operating profit is revenue less every expense except interest, so it leaves out other income and exceptional items. n.m.: not meaningful, because the earlier figure was zero or negative, or the latest one is a loss.

What stood out

  • Revenue grew 63.9% YoY to ₹361.01 crore while volume growth was in the mid-teens, driven by higher LME-linked pricing pass-through and capacity utilization above 80%
    SourceTranscript page 7 & 8 (Anuj Jhunjhunwala); Presentation page 23
  • Operating cash flow turned negative in H1 FY27 due to sharp working capital expansion, with inventories rising from ₹92 crore to ₹154 crore and trade receivables rising from ₹177 crore to ₹207 crore between March and September 2026
    SourceTranscript page 9 & 11 (Akshit Shetty and Anuj Jhunjhunwala); Presentation page 26
  • Capacity expansions at Dahej (15,000 MTPA Phase 1) and Naidupeta (5,000 MTPA brownfield) are scheduled for commissioning in Q3/Q4 FY27, expanding total capacity to 79,904 MTPA
    SourceTranscript page 4 & 9 (Anirudh Jhunjhunwala, Anuj Jhunjhunwala); Presentation page 22

Guidance

MetricGuidancePeriod
FY27 Revenue
SourceTranscript page 14 (Anuj Jhunjhunwala)
Expected to be 'much higher than INR1,200 crores'FY27
Consolidated EBITDA Margin
SourceTranscript page 8 & 15 (Anuj Jhunjhunwala)
Targeting 14% to 15% within 3 years, aided by value-added products and operating leverageNext 3 years (by FY29-FY30)
Non-rubber revenue share
SourceTranscript page 19 (Anuj Jhunjhunwala)
Targeting to increase contribution to 30%Next 2 to 3 years
Net Cash position
SourceTranscript page 7 & 19 (Anuj Jhunjhunwala)
Expected to exceed ₹100 crore by the end of FY27 (vs ₹63.3 crore as of Sept 30, 2026)End of FY27
Dahej Facility Utilization
SourceTranscript page 16 (Anuj Jhunjhunwala)
Expected to operate at 60% to 65% capacity utilization in FY28FY28

Tailwinds

  • Strong demand from the automotive and tyre sectors, supported by a ~₹25,000 crore capex cycle announced by Indian tyre manufacturers
    SourceTranscript page 5 (Anirudh Jhunjhunwala); Presentation page 21
  • Operating leverage expansion, with employee and other expenses growing slower than revenue, sustaining healthy profitability
    SourceTranscript page 9 (Anirudh Jhunjhunwala); Presentation page 23
  • Growing contribution from non-rubber applications, exceeding 18% of sales in H1 FY27 compared to ~10% in FY24
    SourceTranscript page 7 & 19 (Anuj Jhunjhunwala); Presentation page 22

Headwinds

  • Sequential gross margin compression (~130 bps) and EBITDA margin compression (78 bps from 11.50% in Q1 to 10.72% in Q2) due to pricing lags and higher domestic procurement costs amidst shipping disruptions
    SourceTranscript page 8 & 11 (Anuj Jhunjhunwala, Anirudh Jhunjhunwala); Presentation page 23
  • Global supply chain disruptions linked to the West Asia conflict and Ukraine war extending procurement lead times and vessel arrivals
    SourceTranscript page 6 & 11 (Anirudh Jhunjhunwala, Anuj Jhunjhunwala)

New businesses and products

capacity expansion · Equipment installation underway; trial runs scheduled for next month (December 2026)

Dahej Greenfield Facility (Phase 1)

Expected benefit
Adds 15,000 MTPA zinc oxide capacity initially within a planned 40,000+ MTPA site, improving reach into Western India's ceramic, pharma, and chemicals sectors; full project revenue potential of ₹900+ crore
Risks
Lead times for customer qualifications and ramp-up execution
Timeline
Trial runs in December 2026; commercial ramp-up in Q4 FY27/FY28
Investment
₹100 crore (fully funded through internal accruals)
SourceTranscript page 4 & 9; Presentation page 8

capacity expansion · Under installation; target commissioning spilled from Q3 into mid-to-end January 2027 (Q4 FY27)

Naidupeta Brownfield Zinc Oxide Expansion

Expected benefit
Adds approximately 5,000 MTPA to zinc oxide capacity
Risks
Slight project timeline slippage
Timeline
Mid-to-end January 2027 (Q4 FY27)
Investment
Not specified
SourceTranscript page 4 & 9 (Anuj Jhunjhunwala)

new business · Pilot trials completed successfully with key tyre customers; planning full-scale industrial venture with land in place

JG TUR (Tire Upscaled Rubber)

Expected benefit
Entry into the recycled rubber segment to convert end-of-life tires into raw materials for tire makers, expanding product verticals
Risks
Commercialization risks, customer acceptance at scale
Timeline
Commercial implementation timeline to be shared at an appropriate time
Investment
To be shared at an appropriate time
SourceTranscript page 5 & 17 (Anirudh Jhunjhunwala); Presentation page 10

new business · Under incorporation as a step-down wholly owned subsidiary

BDJ Materials and Metals Trading FZCO (Dubai)

Expected benefit
Provides an international base for diversifying zinc raw material sourcing and global distribution of finished products
Risks
Global supply chain disruptions
Timeline
Ongoing incorporation
Investment
Not specified
SourceTranscript page 6 & 18 (Anirudh Jhunjhunwala); Presentation page 22

new product · Launched in H1 FY27; patent pending for rubber curing activator jointly developed with IIT Kharagpur

New Product Commercialization: LabPure and JDZRA

Expected benefit
Supplies analytical grade zinc oxide via e-commerce and specialized curing activators for non-tyre rubber
Risks
Scale and customer adoption
Timeline
Commercialized in H1 FY27
Investment
Supported by the newly inaugurated R&D center at Naidupeta
SourceTranscript page 4-5; Presentation page 12

Things to check

  • Revenue up over 60%: check for an acquisition or a weak year-ago quarter
  • Operating cash flow turned negative in H1 FY27 despite reported PAT of ₹54.07 crore, as working capital absorbed significant cash with inventory jumping 68% (from ₹91.8 crore to ₹154.2 crore) and trade receivables increasing 21% (from ₹171.0 crore to ₹207.3 crore)
    SourceTranscript page 9 & 11; Presentation page 26

How the call went

The call was informative, with management providing clear project commissioning updates, operational data, and frank explanations regarding inventory dynamics and pricing mechanisms.

Specific or vague
Management provided detailed metrics for volume growth (mid-teens), capacity utilization (>80%), working capital cycle (90-100 days), and cash balance targets (>₹100 crore)
Candour
Management directly explained margin pressures stemming from pricing lags/lead-time discrepancies and acknowledged negative operating cash flows due to working capital expansion
The hard questions
Analysts probed working capital stress, cash burn, sequential gross margin contraction, and Naidupeta capex delay, which were answered transparently

What analysts pressed on

  • Negative operating cash flows in H1 FY27 and sharp expansion in inventory and receivables
  • Sequential gross margin reduction of ~130 bps and EBITDA margin contraction
  • Capex delay for Naidupeta brownfield unit moving from Q3 to Q4/mid-to-end January 2027
  • Sustainability of revenue growth if global zinc prices decline

Numbers against the story

Management celebrated record quarterly revenue growth of 63.9% YoY; however, underlying volume growth was in the mid-teens (~14-16%), showing that the majority of revenue growth was driven by higher pass-through zinc commodity prices rather than volume alone. Additionally, while management highlighted strong profitability, EBITDA margin dipped 78 bps QoQ, and cash flows from operations turned negative due to inventory build-up.

Sources

Notes written by gemini-3.8-flash from the documents above on 15 November 2026. They summarise what the company said and can contain mistakes: check the source passage before relying on a point. Not investment advice.